Alector (NASDAQ: ALEC) net income
Alector reported a net loss of $142.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $119.0m. Earnings per share were −$1.39.
Alector's best year of the last 8 was fiscal 2021. It reported a loss in 8 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$142.9m | — | −679.2% | −$1.39 |
| 2024 | −$119.0m | — | −118.4% | −$1.23 |
| 2023 | −$130.4m | — | −134.3% | −$1.56 |
| 2022 | −$133.3m | — | −99.8% | −$1.62 |
| 2021 | −$36.3m | — | −17.5% | −$0.45 |
| 2020 | −$190.2m | — | −901.6% | −$2.45 |
| 2019 | −$105.4m | — | −496.7% | — |
| 2018 | −$52.2m | — | −188.8% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Alector net income compared with its sector
By net income for its latest fiscal year, Alector ranks 374th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Alector, −679.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 372nd | Structure Therapeutics | −$141.2m | — |
| 373rd | ADC Therapeutics | −$142.6m | −175.3% |
| 374th | Alector | −$142.9m | −679.2% |
| 375th | Alphatec | −$143.4m | −18.8% |
| 376th | Upstream Bio | −$143.4m | −5,026.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Alector
- How much did Alector earn in fiscal 2025?
- Alector reported a net loss of $142.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $119.0m.
- What are the earnings per share of Alector?
- They were −$1.39 in fiscal 2025, compared with −$1.23 in fiscal 2024.
- Where does Alector rank in its sector by net income?
- It ranks 374th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Alector come from?
- From the annual report (Form 10-K) that Alector files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Alector files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Alector: the Alector page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.